The deletion of two cancer genes, CHD1 and MAP3K7, improves how well tumors respond to cancer immunotherapy and could be used ...

According to a Phase I study led by researchers at The University of Texas MD Anderson Cancer Center, published today in ...

In attempt to assess treatment patterns in advanced gastric cancer across racial and ethnic groups throughout the U.S., ...

A vitamin A byproduct could weaken the immune system's cancer-fighting ability, according to new Princeton University ...

Immunotherapy has transformed cancer care by helping the immune system recognize and destroy tumors. But new research from ...

Colorectal cancer, the abnormal growth of cancerous cells in the large intestine or the rectum, is one of the most common ...

The tumor microenvironment (TME) is a metabolically dynamic niche where cancer cells and immune cells interact to influence tumor progression and immune ...

Ever-smokers receiving immunotherapy for gastric and esophageal cancers showed better survival outcomes but higher relapse ...

Pelareorep combined with atezolizumab achieved a 29% ORR in heavily pretreated metastatic SCAC patients, significantly ...

Explore the potential of polysaccharide microneedles in cancer immunotherapy for effective drug delivery and immune activation.

Immunotherapy is offering new hope for cancers that once had grim prognoses by harnessing the body's own immune system to ...

A 2024 U.S. national survey reported that 11.8% of males and 7.6% of females ages 12 and older met the criteria for Alcohol ...